San Francisco, CA, United States of America

Thomas S Scanlan

This inventor holds 31 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignees: University of California, Oregon Health & Science University, The United States Government as Represented by the Department of Veterans Affairs. Active years: 1999-2023.

USPTO Granted Patents = 31 (Patent Applications = 8)

% Patents Active = 61.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 6)

Average Co-Inventor Count = 3.4

ph-index = 8

Forward Citations = 231(Granted Patents)

Location History:

San Francisco, CA (US) (1999 - 2022)
Portland, OR (US) (2010 - 2023)

Company Filing History:

20 out of 15,964

University of California

patents

17 out of 523

Oregon Health & Science University

patents

2 out of 952

The United States Government as Represented by the Department of Veterans Affairs

patents

4. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1999-2023

Loading Chart...

Areas of Expertise:

Nuclear Receptor Modulators

Sobetirome

Myelination Diseases

Selective Estrogen Receptor Modulators

Glucocorticoid Receptor

Thyronamine Derivatives

Synthetic Thyroid Hormones

Non-Steroidal Antiandrogens

Peptide Synthesis

Thyroid Hormone Analogues

Pharmaceutical Compositions

Ligand Binding Domains

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11613517 - Amide prodrugs of small molecule nuclear receptor modulators (2023-03-28),

2. 11578032 - Derivatives of sobetirome (2023-02-14),

3. 11510887 - Sobetirome in the treatment of myelination diseases (2022-11-29),

4. 11325886 - Amide compounds, pharmaceutical compositions thereof, and methods of using the same (2022-05-10),

5. 11104654 - Derivatives of sobetirome (2021-08-31),

6. 10870616 - Derivatives of sobetirome (2020-12-22),

7. 10544075 - Derivatives of sobetirome (2020-01-28),

8. 10392356 - Derivatives of sobetirome (2019-08-27),

9. 10226438 - Sobetirome in the treatment of myelination diseases (2019-03-12),

10. 9701650 - Derivatives of sobetirome (2017-07-11),

11. 8263661 - Development of new selective estrogen receptor modulators (2012-09-11),

12. 8236987 - Selective estrogen receptor modulator compositions and methods for treatment of disease (2012-08-07),

13. 7947726 - Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof (2011-05-24),

14. 7645885 - Non-steroidal antiandrogens (2010-01-12),

15. 7485660 - Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof (2009-02-03),

Title: The Inventor Thomas S Scanlan: Pioneering Innovations in San Francisco

Introduction: Thomas S Scanlan is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries through his innovative creations.

Latest Patents: Thomas S Scanlan holds several patents in the fields of technology, healthcare, and sustainability, with his most recent inventions focusing on renewable energy solutions and smart home devices.

Career Highlights: With a career spanning over two decades, Thomas S Scanlan has established himself as a leading figure in the world of innovation, having worked with top companies to bring his ideas to life and improve the quality of everyday living.

Collaborations: Throughout his career, Thomas S Scanlan has collaborated with fellow inventors, engineers, and researchers to push the boundaries of what is possible, resulting in cutting-edge products that have revolutionized their respective industries.

Conclusion: Thomas S Scanlan's passion for innovation and his relentless drive to create a positive impact on society have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to think outside the box and pursue their wildest ideas.